Pharvaris (PHVS) Net Income Growth (1y) (2021 - 2026)
Pharvaris (PHVS) Net Income Growth (1y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Income Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
-88.68% |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
13.34% |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
-43.69% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
-290.15% |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
-73.01% |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
-230.18% |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
59.59% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Pharvaris |
28.66 Bn |
28.37 Bn |
- |
5.89% |
| Date | Value |
|---|
| Mar 31, 2026 |
5.89% |
| Dec 31, 2025 |
-464.49% |
| Sep 30, 2025 |
4.23% |
| Jun 30, 2025 |
-60.46% |
| Mar 31, 2025 |
-60.73% |
| Dec 31, 2024 |
-4.04% |
| Sep 30, 2024 |
-78.44% |
| Jun 30, 2024 |
-34.53% |
| Mar 31, 2024 |
-24.37% |
| Dec 31, 2023 |
13.23% |
| Sep 30, 2023 |
-132.47% |
| Jun 30, 2023 |
-125.21% |
| Mar 31, 2023 |
-35.00% |
| Dec 31, 2022 |
-180.62% |
| Sep 30, 2022 |
-2.61% |
| Jun 30, 2022 |
42.41% |
| Mar 31, 2022 |
-146.94% |
| Dec 31, 2021 |
-11.39% |
| Sep 30, 2021 |
-43.17% |
| Jun 30, 2021 |
-189.25% |
